ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2438

Risk and Severity of Adverse Pregnancy Outcomes in Women with Systemic Sclerosis in Taiwan

Chen I Hsieh1, Shue Fen Luo2 and Chang-Fu Kuo3, 1Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, 2Chang Gung University, Taoyuan County, Taiwan, 3Division of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital, Taoyuan, Taiwan

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: outcomes, pregnancy, risk and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Reproductive Issues in Rheumatic Disorders Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Patients with different autoimmune rheumatic diseases are subject to different pregnancy outcomes because of deviant immunity. Systemic sclerosis is known to be associated with higher risk of poor maternal and fetal-neonatal outcomes, such as scleroderma renal crisis and cardiopulmonary complications. The number of pregnancies in patients with systemic sclerosis are relatively lower than other autoimmune diseases such as systemic lupus erythematosus, ankylosing spondylitis or rheumatoid arthritis in Taiwan. The risks and severity of adverse maternal and neonatal outcomes in systemic sclerosis patients are yet to be documented. This study was designed to analyze the risk of adverse fetal-neonatal and maternal in pregnancies in women with systemic sclerosis in Taiwan.

Methods:

We identified 2338180 singleton pregnancies using the birth registry and National Health Insurance Research Database (NHIRD) of Taiwan from 2001 through 2012. 12159 pregnant women suffered from a autoimmune rheumatic diseases and 60 were systemic sclerosis. We verified adverse maternal outcomes as death, acute myocardial infarction, acute renal injury, acute respiratory distress syndrome, eclampsia, pulmonary hypertension, sepsis, shock, thrombotic embolism and cerebrovascular disorders. Fetal-neonatal adverse outcomes are verified as stillbirth, low birth weight, low 1 and 5 min APGAR score and fetal distress.

To estimate odds ratios (ORs) and 95% confidence intervals (CIs) for pregnancy outcomes we used an adjusted generalized estimating equation model.

Results:

Pregnancy in 60 women with systemic sclerosis were associated with operation on heart and pericardium (OR 24.78 (6.19-99.2)), puerperal cerebrovascular diseases (OR 12.3 (1.73-87.40)), preterm labor (OR 2.43 (1.27-4.68)) and preeclampsia (OR 1.94 (0.62-6.01)). Offspring of women with systemic sclerosis were associated with low birthweight (OR of 2.46 (1.40-4.32)), fetal distress (OR 2.49 (1.25-4.95)), low 1-minute Apgar scores (OR 1.93 (0.62-5.97)) and 5-minute Apgar scores (OR 5.68 (1.45-22.3)). Risks for pregnancy related hypertension (OR 3.06), antepartum hemorrhage (OR 1.52), severe postpartum hemorrhage, and severe postpartum hemorrhage (OR 1.53) were higher in pregnant women with systemic sclerosis. Both maternal and fetal-neonatal outcomes were poor in systemic sclerosis women.

Conclusion:

Women with systemic sclerosis were prone to have a higher risk for adverse maternal and neonatal outcomes especially cerebrovascular events and lower APGAR score. Planned pregnancy and rigorous monitoring of renal function ,blood pressure and signs and symptoms of cerebrovascular diseases are recommended in women with systemic sclerosis.


Disclosure: C. I. Hsieh, None; S. F. Luo, None; C. F. Kuo, None.

To cite this abstract in AMA style:

Hsieh CI, Luo SF, Kuo CF. Risk and Severity of Adverse Pregnancy Outcomes in Women with Systemic Sclerosis in Taiwan [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/risk-and-severity-of-adverse-pregnancy-outcomes-in-women-with-systemic-sclerosis-in-taiwan/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/risk-and-severity-of-adverse-pregnancy-outcomes-in-women-with-systemic-sclerosis-in-taiwan/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology